BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wen P, Gao Y, Chen B, Qi X, Hu G, Xu A, Xia J, Wu L, Lu H, Zhao G. Pan-Cancer Analysis of Radiotherapy Benefits and Immune Infiltration in Multiple Human Cancers. Cancers (Basel) 2020;12:E957. [PMID: 32294976 DOI: 10.3390/cancers12040957] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Cheng Q, Duan W, He S, Li C, Cao H, Liu K, Ye W, Yuan B, Xia Z. Multi-Omics Data Integration Analysis of an Immune-Related Gene Signature in LGG Patients With Epilepsy. Front Cell Dev Biol 2021;9:686909. [PMID: 34336837 DOI: 10.3389/fcell.2021.686909] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Wei XL, Luo TQ, Li JN, Xue ZC, Wang Y, Zhang Y, Chen YB, Peng C. Development and Validation of a Prognostic Classifier Based on Lipid Metabolism-Related Genes in Gastric Cancer. Front Mol Biosci 2021;8:691143. [PMID: 34277706 DOI: 10.3389/fmolb.2021.691143] [Reference Citation Analysis]
3 Dai YH, Wang YF, Shen PC, Lo CH, Yang JF, Lin CS, Chao HL, Huang WY. Radiosensitivity index emerges as a potential biomarker for combined radiotherapy and immunotherapy. NPJ Genom Med 2021;6:40. [PMID: 34078917 DOI: 10.1038/s41525-021-00200-0] [Reference Citation Analysis]
4 Zhang H, Ju Q, Ji J, Zhao Y. Pan-Cancer Analysis Reveals FH as a Potential Prognostic and Immunological Biomarker in Lung Adenocarcinoma. Dis Markers 2021;2021:8554844. [PMID: 34737838 DOI: 10.1155/2021/8554844] [Reference Citation Analysis]
5 Chyuan IT, Chu CL, Hsu PN. Targeting the Tumor Microenvironment for Improving Therapeutic Effectiveness in Cancer Immunotherapy: Focusing on Immune Checkpoint Inhibitors and Combination Therapies. Cancers (Basel) 2021;13:1188. [PMID: 33801815 DOI: 10.3390/cancers13061188] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]